BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

 

OCTOBER 2005

Thrombolytic therapy needs innovation

SOLEXA TO CONDUCT TECHNOLOGY SEMINAR AT THE AMERICAN SOCIETY OF HUMAN GENETICS CONFERENCE

Sigma-Aldrich Strengthens Position in RNAi Through Licensing and Equity Positions in Benitec and Oxford BioMedica

Expert line up at SCIpharm 2006

Minster Pharmaceuticals plc: Annual General Meeting (AGM) statement

Gain in-depth analysis on the avian flu market and future of the antivirals market as a whole

Minster Pharmaceuticals to work with Quintiles on clinical study of tonabersat

Benitec Grants Sigma-Aldrich License to RNAi Patent Portfolio

OXFORD BIOMEDICA SIGNS LENTIVECTOR® LICENSING AGREEMENT WITH FORTUNE 500 BIOPHARMACEUTICAL COMPANY

In Vitro Technologies, Inc. (IVT) and SOLVO Biotechnologies Inc. Announce North American (US and Canada) Distribution Agreement for Solvo’s in vitro ABC Membrane Transporter Assay Products

A biogeneric company leads the field of next generation human growth hormone (hGH)

Epitan begins topical trial of EPT1647 in London

Living Cell Technologies files Pre-IND Request Letter with FDA for its NeurotrophinCell Product

Launch of East Midlands bioscience knowledge exchange initiative

OXFORD BIOMEDICA AND SIGMA-ALDRICH ENTER STRATEGIC ALLIANCE FOR COMMERCIALISATION OF LENTIVECTOR® TECHNOLOGY

Wellcome Trust - Seeding Drug Discovery

Lab21 secures additional IP for Hepatitis C diagnostics

UK TO INVEST IN 120 MILLION DOSES OF PANDEMIC FLU VACCINE: CURRENTLY THERE IS INADEQUATE VACCINE SUPPLY AND TECHNOLOGY ISSUES

TRI announces successful Chilean hospital infrastructure orientation visit and new contract awards.

Epitan Limited completes $6.9 million capital raising

Liponex names Kenneth Sokoll Vice President of Drug Development

OXFORD BIOMEDICA ANNOUNCES PRESENTATION BY WYETH PHARMACEUTICALS OF PRECLINICAL EFFICACY DATA WITH ANTIBODY-TARGETED THERAPY FOR CANCER

SOLEXA ANNOUNCES MAJOR SEQUENCING PROGRESS AND TARGETS WHOLE HUMAN GENOME

Apollo Life Sciences: Clinical Trial for Psoriasis Treatment Commences

OXFORD BIOMEDICA ANNOUNCES PRESENTATION BY CLINICIAN OF PHASE II RESULTS WITH METXIA® IN PANCREATIC CANCER

Oxford Genome Sciences licences OGAP database to UCB

Sigma-Aldrich Introduces New Vectors to Increase the Flexibility of the TargeTron Gene Knockout System

Northbank Communications Client List "Sparkles" following Diamond Light Source Win

MNLPHARMA AND US GOVERNMENT NIH COLLABORATION IDENTIFIES EARLY ANTI-VIRAL HITS

Inpharmatica licenses Biopendium(TM) to Schering AG and announces druggability collaboration

Too many companies with biogeneric G-CSF products compete for a small market

Capsulution NanoScience AG participates in NanoforLife Programme Federal Ministry of Research supports Nanotechnology

OXFORD BIOMEDICA PRESENTs encouraging final PHASE II results with TROVAX® IN COLORECTAL CANCER AT the international colorectal cancer congress

Biotech crops can contribute to alleviating poverty and malnutrition

Sigma-Aldrich Introduces the MyriaScreen Diversity Collection for Drug Discovery

Minster Pharmaceuticals and the University of Buckingham investigate potential of sabcomeline in Type 2 diabetes

German research giant to close its first spin-off fund

Neurotech Names Ted Danse as New President and CEO

BIOINVENT INTERIM REPORT: 1 JANUARY - 30 SEPTEMBER 2005

BIOINVENT TO ISSUE SHARES AND PROGRESS CLINICAL DEVELOPMENT

Smaller is better for thrombopoiesis-stimulating agents

Patent expiry of epoetin alfa in Europe attracts 10 companies with biogeneric erythropoietin

Capsulution NanoScience AG Starts New Feasibility Studies

New Fly-By Bar Code Reader Confirms and Tracks Plate and Sample Identification

Inpharmatica licenses Admensa Interactive(TM) to Mochida of Japan

InforSense and Elsevier MDL Expand Strategic Relationship

Unique Map of Human Protein Interactions Created RZPD provides verified ORF-Clones

Biotech Crops Reduce Pesticide Use, Greenhouse Gas Emissions Planting of these crops generates additional US$27.5 billion in global farm income

Austrianova and Miltenyi Biotec: Strategic partnership to manufacture NovaCaps® – the world's first allogeneic product to combat pancreatic cancer

Oxford Immunotec appoints Chief Financial Officer

Sigma-Aldrich Launches Functional Cancer Protein Microarray

Innate Pharma completes its management team with the recruitment of Dr. Patrick Squiban as Chief Medical Officer

Eyes turning to neuropathic pain market

Bush Pushes For Mass-Produced Avian Flu Vaccine: Dna-Based Vaccine From UK-Based Company Offers Hope For Rapid Response

Opal Healthcare and IQA announce collaborative agreement

Sigma-Aldrich Offers Another New Format of The RNAi Consortium (TRC) shRNA Libraries

Oxford Biomedica Announces Encouraging Preliminary Phase Ii Results With Trovax In Renal Cell Carcinoma

Synbiosis Automated Colony Counter at Major Disinfectant Manufacturer Cuts Quality Control Time in Half, Without Compromising Accuracy

Olympus launches the new modular fully flexible cell family of imaging systems for the life sciences

Haptogen directors triumph Winners of Ernst and Young UK Entrepreneur of the Year award

West Pharmaceutical Services Names Don McMillan President

Robert Hargesheimer Appointed President of The Tech Group

USC Marshall School of Business Announces Six Nominees for European BioBusiness Leadership Award 2005

FDA feedback and expert panel review positive for Avexa

MEDITECH MEETS WITH FDA - INVESTIGATIONAL NEW DRUG FILING FOR 2006

Cytotoxics remain standard bearers

The Board of International Biotechnology Trust Plc (“IBT”) today announces its unaudited Annual Results for the twelve months ended 31 August 2005

MOUSE GENES OFF THE SHELF Geneservice and RZPD to distribute DNABookTM

York Pharma founds Japanese operating company and appoints President

BioNewsCast Press Release Service 2006 Archive - January 2006 ~ February 2006 ~ March 2006 ~ April 2006 ~ June 2006

BioNewsCast Press Release Service 2005 Archive - December 2005 ~ November 2005 ~ October 2005

BioNewsCast Press Release Service 2004 Archive

BioNewsCast Press Release Service 2003 Archive

BioNewsCast Press Release Service 2002 Archive

Site Map - new news site

Site Map - old news site
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.